Literature DB >> 31656426

Mycobacterium bovis epidural abscess following Bacillus Calmette-Guerin therapy for bladder cancer.

Hanish Jain1, Kunal Gada1, Syed Zaidi1, Elizabeth Asiago-Reddy1, Ambika Eranki1.   

Abstract

Bacillus Calmette-Guerin (BCG) is derived from attenuated Mycobacterium bovis. It is the most common intravesical immunotherapy for treating early stage bladder cancer. Pott's disease is a form of mycobacterial infection that involves the vertebrae. This case highlights an unusual presentation of epidural abscess infection with M. bovis following BCG therapy for bladder cancer.
© 2019 Baylor University Medical Center.

Entities:  

Keywords:  Bacillus Calmette-Guerin; Mycobacterium bovis; bladder cancer; epidural abscess

Year:  2019        PMID： 31656426      PMCID： PMC6793995          DOI： 10.1080/08998280.2019.1647714

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


  12 in total

1.  Vertebral osteomyelitis after intravesical administration of bacille Calmette-Guérin.

Authors:  R Civen; G Berlin; C Panosian
Journal:  Clin Infect Dis       Date:  1994-06       Impact factor: 9.079

Review 2.  Complications of bacillus Calmette-Guérin immunotherapy.

Authors:  D L Lamm
Journal:  Urol Clin North Am       Date:  1992-08       Impact factor: 2.241

3.  Mycobacterium bovis BCG causing vertebral osteomyelitis (Pott's disease) following intravesical BCG therapy.

Authors:  I S Aljada; J K Crane; N Corriere; D G Wagle; D Amsterdam
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

Review 4.  Mycobacterium bovis vertebral osteomyelitis as a complication of intravesical BCG use.

Authors:  Rima Abu-Nader; Christine L Terrell
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

5.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

6.  The persistence of bacille Calmette-Guérin in the bladder after intravesical treatment for bladder cancer.

Authors:  L Bowyer; R R Hall; J Reading; M M Marsh
Journal:  Br J Urol       Date:  1995-02

7.  Late Mycobacterium bovis spondylitis after intravesical BCG therapy.

Authors:  Andreas F Mavrogenis; Vasileios I Sakellariou; Sotirios Tsiodras; Panayiotis J Papagelopoulos
Journal:  Joint Bone Spine       Date:  2009-03-19       Impact factor: 4.929

8.  Mycobacterium bovis spondylodiscitis after intravesical Bacillus Calmette-Guérin therapy.

Authors:  Sami Obaid; Alexander G Weil; Ralph Rahme; Cathy Gendron; Daniel Shedid
Journal:  Surg Neurol Int       Date:  2011-11-14

Review 9.  Immunotherapy for bladder cancer.

Authors:  Oliver Fuge; Nikhil Vasdev; Paula Allchorne; James Sa Green
Journal:  Res Rep Urol       Date:  2015-05-04

Review 10.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.